Search

Search Constraints

You searched for: Author/Creator Knight, R.D.

Search Results

1. Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS). (April 2017)